Posts by: Caroline McGarry

HIHI Meet the Team. HIHI welcomes Laura Caden as HIHI Health Technology Innovation Specialist

  |   By  |  0 Comments

HIHI is delighted to welcome Laura Caden to our team. She joins as Health Technology Innovation Specialist, based at Mater Misericordiae​ University Hospital

Laura brings a wealth of experience to Health Innovation Hub Ireland. She has worked across all sectors of the medical device industry inclusive of start-ups, multinationals and corporations looking to diversify their business portfolios into medical device design and manufacture.  Her experience to date includes the design and development of novel Med Tech applications from conceptualisation and prototyping as well as supporting clinical trials through to commercialisation readiness.

Laura has a B. Eng in Biomedical Engineering from NUI Galway,  an MSc. in Mobile Application Design from TUD, and recently completed a post graduate certificate in Creativity, Innovation and Entrepreneurship with UCD.

In her role she will support the submission and progression of ideas put forward through the HIHI Innovation Portal, as well as delivery of pilot studies and end user evaluations. Laura will work with HIHI and health care professionals/staff based at MMUH, to drive innovation and create powerful and disruptive technology that improves patient outcomes and clinician experience.

HIHI Senior Clinical Research Manager takes part in the World Congress on Virtual Rehabilitation. UCC researchers collaborate with European partners on virtual healthcare rehabilitation with the aim of reducing waiting lists

  |   By  |  0 Comments

HIHI Senior Clinical Research Manager, Dr. Michael Twomey recently participated in the 2024 World Congress on Virtual Rehabilitation which was held in Amsterdam in the Netherlands in June 2024.  ​​​​​​​​​​​​​​​​​​​​​​​​

University College Cork (UCC) researchers are collaborating with European partners in a new 5-year project aimed at providing a platform that offers access to virtual rehabilitation therapies for those most in need, thus reducing healthcare rehabilitation waiting lists. Scale-Up4Rehab, an Interreg North-West Europe (NWE) grant involving 13 European partners across clinical and research and development sectors, represents a major advancement in the digitalisation of rehabilitation services across Europe. The project aims to develop an open NWE virtual rehabilitation clinic similar in design to platforms such as Netflix, through which existing virtual rehabilitation therapies will be piloted and scaled up.

The response of healthcare services to the Covid-19 pandemic has demonstrated opportunities that digital solutions offer in terms of access, efficiency and effectiveness. Following professional assessment and individualised treatments prescribed by clinicians, digital rehabilitation harnesses the latest virtual reality technology and will offer access to dedicated rehabilitation care regardless of the location of the patient.

Scale-Up4Rehab aims to ensure equal access to rehabilitation care and foster the resilience of healthcare systems throughout North-West Europe. European partners in rehabilitation clinics, medical centres and innovation networks, along with experts in research and development in engineering and computer science will collaborate on the project over a five-year period.

Dr Joseph McVeigh, Head of Discipline of Physiotherapy and Mr David Murphy, School of Computer Science and Information Technology, lead UCC’s involvement in the €10.8 million project, with almost €1 million allocated to UCC.

Five regional pilots in Ireland, the Netherlands, Germany, Belgium and Luxemburg, will establish the feasibility of the virtual rehabilitation clinic across a range of conditions such as stroke, back pain, Parkinson’s disease and cerebral palsy. The UCC team (Dr Joseph McVeigh, Mr David Murphy, Mr Eoghan Ó Riain, Mr Aaron Cole, Ms Ciara Hanrahan, Mr Declan O’Sullivan, Ms Trish O’Sullivan and Dr Michael Twomey), working with the other Irish partner University College Dublin (UCD), will focus on people with chronic pain and long covid.

Dr McVeigh expects the project to significantly improve access to effective rehabilitation services for patients.

Waiting lists across a range of rehabilitation services are far too long. Patients need early and appropriate interventions. Digital solutions offer the potential to deliver rehabilitation earlier, faster, and direct to their home. All patients will continue to require bespoke individualised care that is appropriate for their needs at any time, but we also need to be open to the opportunities and improvements that technology can offer patients,” Dr McVeigh said.

Scale-Up4Rehab aims to develop applications that meet the highest standards of efficacy and effectiveness, as well as having high acceptance amongst healthcare professionals and patients.

We need a clear set of requirements for applications to create a scalable virtual rehabilitation clinic. These requirements will cover medical, technical, and legal criteria,” said David Murphy.

The project will also embed digital rehabilitation into the physiotherapy curriculum at UCC, exposing students to digital technologies and digital rehabilitation early in their training. “At UCC we are training physiotherapists not just for today and tomorrow but for many years to come. While it is widely accepted that physiotherapists are evidence-based and research led, physiotherapists of the future need to be equipped with the skills to work with future digital technologies. We want our students at UCC to be leaders in this field,” added Dr McVeigh.

Commenting on the Scale-Up4Rehab project, Professor John Cryan, Vice-President of Research and Innovation at UCC said:

“This project represents a fantastic opportunity to revolutionise rehabilitation services in the healthcare system, providing solutions to the challenges associated with rehabilitation care and recovery. Significantly, it will also embed research-led innovative technological solutions into our physiotherapy curriculum at UCC.

 

 

HIHI launches latest Clinical Evaluation study with CergenX which provides new hope for early recognition of potential brain injury in newborns

  |   By  |  0 Comments

This July, HIHI is spotlighting our latest Clinical Evaluation Study with CergenX with their product CergenX Wave which provides new hope for early recognition of potential Brain Injury in Newborns.

At least 5 out of every 1,000 newborns in the developed world have some form of brain injury at  birth. Newborn brain injuries are frequently clinically invisible and can be undiagnosed at birth, resulting in lifelong consequences for not only the infant but also their families and society. In the USA, the lifetime care costs for an individual born with brain injury can be up to $3 million. Currently, EEG (electroencephalography) is the gold standard for detecting brain function issues. However, its widespread use is limited by several factors: it requires specialised expertise for analysis, results can take hours to days, it is costly, and scaling up its availability has proven challenging.

CergenX is a high-potential start-up supported by Enterprise Ireland and a spin-out from Infant Research Centre at University College Cork has developed a groundbreaking solution. The CergenX Wave is an innovative two-channel EEG device integrated with artificial intelligence (AI). This device allows for the early recognition of potential brain injury in all infants, facilitating timely intervention, leading to reduced infant morbidity, improved developmental outcomes, and decreased severity of brain injuries. The Role of HIHI  was crucial in assisting CergenX on their innovation journey.

HIHI facilitated the evaluation of the CergenX Wave by organising focus groups with neonatal healthcare professionals across multiple hospitals (Cork University Hospital, Galway University Hospital, Portiuncula Hospital in Galway, and St Luke’s General Hospital in Kilkenny).HIHI identified and recruited participants, coordinated sessions, and helped design the presentations and questions to gather insightful feedback.

HIHI also analysed the data and prepared a comprehensive report, aiding CergenX in refining their product to better meet clinical needs. This project underscored the importance of early detection tools in neonatal brain health and demonstrated the significant impact such innovations can have on improving outcomes for newborns and their families.

Jason Mowles, CergenX CEO commented on the valuable role of HIHI on their innovation journey: “Medical professionals have notoriously busy schedules, but HIHI has the network and relationships that allowed us to secure time with the people we needed to speak to. Their ability to engage relevant healthcare professionals to gather crucial insights has significantly contributed to refining CergenX Wave. We collaborated closely with Michael and Maria to maximise the value of every session. No ask was too great—they were a pleasure to work with.”

Read the full case study here : https://hih.ie/downloads/case-studies/HIHI-case-study_Cergenx.pdf

Do you want to be a national leader in healthcare innovation? One month to apply to the Postgraduate Diploma in Healthcare Innovation

   |   By  |  0 Comments

If you want to be at the forefront of healthcare innovation leadership and become an innovation champion of the future then apply today to the Postgraduate Diploma in Healthcare Innovation. This one year course is run by Trinity College Dublin in association with Health Innovation Hub Ireland. Accelerate your career and lead the delivery of innovation impact across Irish healthcare. The closing date is approaching so apply now by 30th June, 2024.

By enrolling in this programme you will:

  • Develop your personal and professional capacity to lead in healthcare.
  • Practical understanding of applying new technologies in healthcare.
  • Critically appraise innovation theory and practice to inform your approach in applying solutions that are at the forefront of global healthcare.
  • Examine the role of health economics, quality improvement and the principles of governance in leading effective innovative health services.
  • Deepen your ability to challenge current practice with novel proven solutions.
  • Develop you as an innovation practitioner with the skills to implement innovative leadership practices.
  • Progress you to effectively manage and lead in diverse healthcare settings.

Graduates of the Postgraduate Diploma in Healthcare Innovation form part of a year-on-year a growing network of national Innovation Champions.

Please find additional course information and online application form here https://www.tcd.ie/medicine/clinical-medicine/postgraduate/pgraddip-in-healthcare-innovation/

For course-related queries, please e-mail: Dr. Michelle Armstrong (Course Co-Ordinator) or Dr. Alison Keogh (Academic Co-ordinator) at pgdip.healthcareinnovation@tcd.ie

Watch the course informational videos to find out more. 

YouTube player
YouTube player

Health Innovation Hub Ireland collaborates with Galway University Hospital and Atlantic Technological University on design driven healthcare solutions

  |   By  |  0 Comments

A collaboration between HIHI and UHG and ATU’s Industrial Design third-year students has recently wrapped up with a very successful demonstration of the intersection of healthcare and design thinking.

HIHI’s Michael Duane, Clinician Liaison and Principal Engineer for HIHI, Medical Physics and Clinical Engineering together with Kenneth Nevin, Lecturer in Product & Industrial Design, MSc Design Innovation, oversaw the program within the hospital. The initiative immersed third-year students in various hospital departments, where they addressed real-world problems encountered by clinicians daily and embarked on a design process which involved presentations by clinicians on their needs. Through iterative dialogues with clinical staff, the students refined their concepts and this hands-on approach ensured that the designs addressed the practical needs of the hospital environment.

The semester-long collaboration culminated in new product designs being presented to clinical staff which highlighted the synergy between the students’ fresh perspectives and the clinical expertise of the hospital staff. The success of this module has set the stage for a new partnership between Atlantic Technological University and the hospital, promising a future where design-led solutions continue to enhance healthcare delivery.

Great coverage of HIHI’s pilot with Telea in Irish Medical Times

  |   By  |  0 Comments

Read a great article by Terence Cosgrave editor of the Irish Medical Times on how Irish start-up Telea is helping Parkinson’s speech therapy. Health Innovation Hub Ireland has recently completed a pilot with Telea which was launched on World Parkinsons Day this year. This new home therapy platform offers new hope to the 12,000 Irish people living with the disease.

Read the article in the IMT here. https://www.imt.ie/features-opinion/software-helps-parkinsons-speech-therapy-22-05-2024/

Read the full case study here. https://hih.ie/downloads/case-studies/HIHI-case-study_Telea2.pdf

Spotlight on the winners of HIHI/EI Clinical Innovation Awards 2023

  |   By  |  0 Comments

This May we at Health Innovation Hub Ireland are delighted to spotlight the winners of the HIHI/EI Clinical Innovation Awards 2023, Dr. Conor Judge, Dr. Claire Stenson and Dr. Declan Sheppard. The winners were recently announced at the Enterprise Ireland Start Up Showcase 2024.

HIHI’s Clinical Innovation Award is designed to support all healthcare professionals in Ireland to explore the commercial potential of their innovative ideas. The three winners this year received a €15,000 EI Commercial Feasibility Fund. Additionally, the Department of Health Ireland are funding three places for them on the prestigious NHS Clinical Entrepreneur Programme.

First up to be profiled is the overall winner, Dr Conor Judge, Consultant Nephrologist, University Hospital Galway and Senior Lecturer in Applied Clinical Data Analytics at the University of Galway.

Dr. Judge’s winning product, an AI Revolutionizing Hypertension Management platform (AI-BP) provides comprehensive, real-time treatment decisions with personalised recommendations for those with high blood pressure (hypertension) based on clinical trial data. The data used is from randomised controlled trials to predict complex treatment decisions for patients with hypertension. It is a testament to his commitment to pushing the boundaries of what is possible with AI in healthcare and it aims to provide early intervention and effective hypertension management for patients.

Next we profile Dr. Claire Stenson with her winning product, Smart Pleuro.

Dr. Stenson, a surgical trainee, graduated from the RCSI  in 2021. Having completed her intern year in Beaumont Hospital, Dr. Stenson undertook a clinical tutor role in RCSI / Beaumont Hospital last year and she has previously been involved in MedTech Innovator and HSE Spark Innovation.

Malignant Pleural effusions (MPE), with an incidence of 150,000 new cases a year, have been identified as a cause of significant morbidity in advanced cancer patients. MPE is the accumulation of fluid between the lung and chest wall as a result of cancer. Current solutions fail up to 50% of the time requiring repeat hospitalisation, re-intervention and overall, negatively impacting patients’ quality of life. Dr. Stenson aims to develop a device to better treat patients with malignant pleural effusion with Smart Pleuro.

Focusing on another winner, Dr. Declan Sheppard Consultant Radiologist, University Hospital Galway with his Mobile phone Vascular access Ultrasound (MVU)

Dr. Sheppard has an interest in diagnostic and interventional radiology especially Oncology and holds a Cardiac CT level 3 accreditation. Dr Sheppard graduated from Trinity College Dublin and trained in Radiology in Glasgow before embarking on fellowship training in the University of Texas MD Anderson Cancer Centre Houston Texas, in Oncological Imaging, and Cardiovascular Imaging in Northwestern Memorial Hospital Chicago Illinois, US.

The winning product, Mobile phone Vascular access Ultrasound (MVU) is Dr. Sheppard’s solution and is a novel ultrasound device that will be more portable and accessible than the current state of the art solutions. The device will assist clinicians care for patients and successfully gain access to challenging veins. The device will be small and attachable to a mobile phone thereby improving its usability in all clinical settings. Delays in obtaining venous (vein) access can result in delayed blood sampling, delays in diagnosis, resulting in delays in treatment, which may escalate to a need for an invasive Central Venous Catheter insertion that has higher complication rates.  Multiple attempts to obtain venous access can lead to phlebitis, thrombosis, and catheter related infection. For those placing peripheral venous access early ultrasound evaluation can be very valuable to ensure venous patency

Health Innovation Hub Ireland launches first GreenTech @ HIHI sustainable healthcare pilot study

   |   By  |  0 Comments

Healthcare contributes 4.4% to global greenhouse gas emissions. Ireland currently ranks as a major emitter (between 0.5 and 1 million t) when compared to other countries. There is a growing need to reduce healthcare emissions in order to reduce Ireland’s impact on the global carbon footprint.

In line with the HSE’s objectives to ‘reduce the impact of climate change and promote greener approaches to health practices’ one of HIHI’s focus areas is on alternatives and improvements to single use products within healthcare.

In response, HIHI today launches it’s first GreenTech sustainable healthcare pilot study with Ecco Spray Ltd. The product, POCUS Spray is CE approved for use in healthcare and designed to be an alternative, more sustainable ultrasound medium to be used across a range of ultrasound services. HIHI supported a technical evaluation of the product in Tallaght University Hospital (TUH) as well as collecting anonymised feedback from clinicians. POCUS Spray is a water-based spray stored in a 50 ml spray bottle. The spray averages 18 examinations per 50ml bottle with no requirement for paper towels post exam as the spray naturally evaporates after 4-5 minutes. This attribute also leaves no residue on the probe head. Overall waste is reduced with less bottles, paper towels and less plastics.

Explore the full case study here https://hih.ie/downloads/case-studies/HIHI-case-study_GreenTech.pdf

Coming soon to GreenTech @ HIHI
In Autumn this year watch out for HIHI’s first GreenTech sustainable healthcare call competition.
Stay tuned for details and how to apply!

HIHI launches new pilot study on a digital health app “I Know Me” which is set to empower CF patients to become the “CEO” of their own bodies with more control over personal health data

   |   By  |  0 Comments

Cork, 15th May, 2024. May marks Cystic Fibrosis (CF) Awareness Month and this year’s focused theme is Resilient. CF is a genetic disease which affects the lungs and the digestive system and is caused by mutations in the CFFTR gene which leads to the production of a thick sticky mucus in the lungs and it can also affect other organs. According to the Cystic Fibrosis Foundation approximately 1,000 new cases of CF are diagnosed each year. More than 75 percent of people with CF are diagnosed by age 2. More than half of the CF population is age 18 or older.

Resilience certainly applies to Dr. Michael Twomey a Cork native who is living with CF. Michael as well as being the founder of the I Know Me app also works as a Senior Clinical Research Manager at Health Innovation Hub Ireland which connects innovators with healthcare. (pictured) Michael’s own research and innovation journey is a very personal one, motivated by the death of his sister from CF in 1997. Based on his own life and patient journey he strove to address the problem faced by fellow CF patients and carers, the challenge of recalling medical history at medical appointments. He was concerned about providing accurate information to his own clinicians and he decided to do something about it, as poor quality information imparted by patients or their carers is known to affect patient outcomes.

For patients with CF, there are a number of medical appointments necessary to manage the disease and improve or maintain the CF’s patient’s condition. The aim of the appointment is to arrive at correct diagnosis and make decisions regarding appropriate treatment plans. One of the key data facets required by the clinician in the diagnostic process is accurate medical history supplied by the patient or carer.  This information is a complex tapestry of illnesses, medications, symptoms and procedures peppered with medical appointments. which can be difficult to recall accurately. Memory recall requires the patient to pull data from their long-term declarative memory, a process that is made more difficult by the nature of the medical encounter itself, which can be stressful and require a medical literacy that many struggle with.

With this in mind, Michael came up a number of solutions to this problem, first a paper-based checklist booklet which was sent out to every CF patient in Ireland, and then following the learning from same he designed and developed the I Know Me app. This was again done with the help of fellow CF patients and caregivers which basically means it’s designed by CF patients or carers for CF patients or carers. The app was specifically built and evaluated to address the above problem of poor CF patient/carer memory recall. The I Know Me design is based on current CF medical appointment workflows, CF patient / carer experiences, and helps the patient/carer record, track and report on key aspects of their medical history. These reports can then be shared with a patient’s clinical team if and when required. Additionally, the app allows for the capture of multiple health profiles on one device, where switching between profiles is easy. This component of the app is vital for families with more than one CF patient.

Some of the app features are the ability to provide the CF patient with a valuable health management tool, tracking symptoms, key metrics, vaccines, nutrition, physiotherapy, medications and other treatments and procedures (including the results of same). Furthermore, it allows patient and carers to bring their or their child’s health autobiography with them to the medical appointment, reducing the stress of having to recall and providing the clinician with better quality data. Not only that it also allows for the capture of data regarding what happened within the medical appointment itself, this is vital later when the patient or carer need to remember therapies, procedures etc. Not surprising then that this information will aid adherence to therapies. But possibly the most interesting feature of the app is that it generates reports based on metrics which allows the CF patient to track changes and development in health status over time. The portability and accessibility of the solution not only aids memory recall it also empowers patients and carers giving them peace of mind when they travel (as they now have their medical histories with them) and go about their busy lives.

Today, Health Innovation Hub Ireland launched the results of the pilot study of this digital health app which is set to be a gamechanger for people living with CF as it now enables patients to manage their medical history more effectively. HIHI conducted a pilot of the I Know Me app with 15 CF patients/carers within Ireland, including the facilitation of a number of design workshops which helped offer a dynamic and inclusive approach to problem solving, enabling participants to create a solution that is not only functional, but also deeply resonant with CF patients/carers. HIHI analysed the pilot results (end-user feedback) and prepared a final project report to disseminate the outcome of the pilot. The project was granted ethical approval by the SREC in University College Cork.

When tested with patients and carers during the pilot it was agreed that the app is an essential tool for CF patients with 93% of users saying that it improved memory recall. Additionally, it was found that:

93% Agreed or Strongly Agreed that the app was easy to navigate

87% Agreed or Strongly Agreed that using the app requires a change in behaviour

86% Agreed or Strongly Agreed that the app was easy to use

67% stating that it was Very or Extremely useful for memory recall of medical history.

67% Agreed or Strongly Agreed that using the app gave them a real sense of empowerment

67% of participants use the app on a weekly or monthly basis

60% Agreed or Strongly Agreed that using the app helped reduce their stress levels within the medical appointment.

The pilot results will come as welcome news to CF patients as in Ireland, there are almost 1,700 Irish people living with the disease and 70,000 CF patients worldwide.

Speaking on the release of HIHI’s I Know Me pilot study today, Dr. Michael Twomey the founder of app said: I Know Me is an app for us (CF patients / carers) designed by us, that’s why it works! It allows us to track our medications, our symptoms etc more effectively, our own unique health journeys, with the data captured available to us as required. We are empowered in the management of our own health and need to be. After-all, we need to be the CEOs of our own bodies! I’m delighted that we are making such progress, the insights gained from the pilot have been invaluable and will really aid our advancement of the I Know Me app. Still more work to be done, I hope my sister (who passed away with CF in 1997) would be proud of what we have done so far.”

Praise from one of the CF patients on the pilotI really like the way the app gives you visuals on key metrics and allows one to generate reports that can be sent / given to the clinical team. It’s wonderful to be able to refer to the app with confidence re my medical history”

Read the full case study here I Know Me (hih.ie)

The I Know Me app is free and is available on Google Play and can also be downloaded from the Apple App store.

Details of the app can be found on this link https://iknowme.info/

 

 

Health Innovation Hub Ireland commences new AI pilot study which is set to improve the accuracy of bladder scans with Cardiogenics and the Urology Department at University Hospital Galway

  |   By  |  0 Comments

Great to kick off another Health Innovation Hub Ireland pilot study!

HIHI’s Galway office are currently working on an AI tool with Cardiogenics and the Urology Department of University Hospital Galway. (UHG). The pilot study using the Vitacon Bladder Scanner involves the collection of anonymous scan images supplied by the company which will serve as training data for an AI model. The aim is to improve it’s ability to accurately detect the edges of the bladder wall, achieved through a Convolutional Neural Network (CNN), a type of deep-learning model which proves effective at tasks such as image classification and medical image analysis.

The pilot marks a step forward in the use of AI in healthcare and has the potential to improve the accuracy of bladder scans and ultimately enhance patient care.

Pictured at the pilot launch are Brian Turvey (Cardiogenics), Geraldine Rooney Urology ANP UHG, Therese Kelly Urology ANP UHG and Michael Duane MPCE/HIHI